GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
114 hedge funds and large institutions have $541M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
114
Holding in Top 10
–
Calls
$7.08M
Puts
$6.33M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$7.46M | |
| 3 | +$5.55M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$5.17M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$14.5M | |
| 3 | -$4.7M | |
| 4 |
Goldman Sachs
New York
|
-$2.86M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$2.55M |